46 related articles for article (PubMed ID: 22551)
1. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells.
Madden MZ; Ye X; Chi C; Fisher EL; Wolf MM; Needle GA; Bader JE; Patterson AR; Reinfeld BI; Landis MD; Hathaway ES; Muka JE; O'Neil RT; Karijolich J; Philip M; Rathmell JC
J Immunol; 2023 Aug; 211(4):563-575. PubMed ID: 37341499
[TBL] [Abstract][Full Text] [Related]
3. Discovery of
Novotná K; Tenora L; Prchalová E; Paule J; Alt J; Veeravalli V; Lam J; Wu Y; Šnajdr I; Gori S; Mettu VS; Tsukamoto T; Majer P; Slusher BS; Rais R
J Med Chem; 2023 Nov; 66(22):15493-15510. PubMed ID: 37949450
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo.
Crosby HA; Miller KE
Pharm Pharmacol Int J; 2016; 3(3):. PubMed ID: 29888760
[TBL] [Abstract][Full Text] [Related]
5. Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy.
Cervantes-Madrid D; Romero Y; Dueñas-González A
Biomed Res Int; 2015; 2015():690492. PubMed ID: 26425550
[TBL] [Abstract][Full Text] [Related]
6. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma.
Recouvreux MV; Grenier SF; Zhang Y; Esparza E; Lambies G; Galapate CM; Maganti S; Duong-Polk K; Bhullar D; Naeem R; Scott DA; Lowy AM; Tiriac H; Commisso C
Nat Cancer; 2024 Jan; 5(1):100-113. PubMed ID: 37814011
[TBL] [Abstract][Full Text] [Related]
7. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.
Encarnación-Rosado J; Sohn ASW; Biancur DE; Lin EY; Osorio-Vasquez V; Rodrick T; González-Baerga D; Zhao E; Yokoyama Y; Simeone DM; Jones DR; Parker SJ; Wild R; Kimmelman AC
Nat Cancer; 2024 Jan; 5(1):85-99. PubMed ID: 37814010
[TBL] [Abstract][Full Text] [Related]
8. DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism.
Pillai R; Papagiannakopoulous T
Cancer Res; 2024 Feb; 84(3):349-350. PubMed ID: 38117482
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-activated glutamine antagonist prodrug combined with combretastatin A4 nanoparticles for tumor-selective metabolic blockade.
Zheng M; Xu H; Huang Y; Sun J; Zhang H; Lv Z; Liu Z; Tang Z; Chen X
J Control Release; 2024 Jan; 365():480-490. PubMed ID: 38040341
[TBL] [Abstract][Full Text] [Related]
10. Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregates.
Wu F; Bergström M; Stridsberg M; Orlefors H; Eriksson B; Oberg K; Watanabe Y; Långstrom B
Anticancer Res; 1997; 17(4A):2363-7. PubMed ID: 9252648
[TBL] [Abstract][Full Text] [Related]
11. Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Thomas AG; O'Driscoll CM; Bressler J; Kaufmann W; Rojas CJ; Slusher BS
Biochem Biophys Res Commun; 2014 Jan; 443(1):32-6. PubMed ID: 24269238
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Subpocket Enables the Discovery of Thiadiazole-Pyridazine Derivatives as Glutaminase C Inhibitors.
Sun H; Du T; Yang M; Liu X; Xue X; Chen K; Lang X; Chen X; Wang B; Wang X
ACS Med Chem Lett; 2023 Oct; 14(10):1455-1466. PubMed ID: 37849538
[TBL] [Abstract][Full Text] [Related]
13. The Intricate Metabolism of Pancreatic Cancers.
Camelo F; Le A
Adv Exp Med Biol; 2021; 1311():77-88. PubMed ID: 34014535
[TBL] [Abstract][Full Text] [Related]
14. Glutamine Metabolism in Cancer.
Li T; Copeland C; Le A
Adv Exp Med Biol; 2021; 1311():17-38. PubMed ID: 34014532
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cancer Metabolism and Current Anti-Cancer Drugs.
Sukjoi W; Ngamkham J; Attwood PV; Jitrapakdee S
Adv Exp Med Biol; 2021; 1286():15-48. PubMed ID: 33725343
[TBL] [Abstract][Full Text] [Related]
16. Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties.
Soth MJ; Le K; Di Francesco ME; Hamilton MM; Liu G; Burke JP; Carroll CL; Kovacs JJ; Bardenhagen JP; Bristow CA; Cardozo M; Czako B; de Stanchina E; Feng N; Garvey JR; Gay JP; Do MKG; Greer J; Han M; Harris A; Herrera Z; Huang S; Giuliani V; Jiang Y; Johnson SB; Johnson TA; Kang Z; Leonard PG; Liu Z; McAfoos T; Miller M; Morlacchi P; Mullinax RA; Palmer WS; Pang J; Rogers N; Rudin CM; Shepard HE; Spencer ND; Theroff J; Wu Q; Xu A; Yau JA; Draetta G; Toniatti C; Heffernan TP; Jones P
J Med Chem; 2020 Nov; 63(21):12957-12977. PubMed ID: 33118821
[TBL] [Abstract][Full Text] [Related]
17. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
[TBL] [Abstract][Full Text] [Related]
18. Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation.
Katt WP; Ramachandran S; Erickson JW; Cerione RA
Mol Cancer Ther; 2012 Jun; 11(6):1269-78. PubMed ID: 22496480
[TBL] [Abstract][Full Text] [Related]
19. A simple method for measuring intracellular activities of glutamine synthetase and glutaminase in glial cells.
Mongin AA; Hyzinski-García MC; Vincent MY; Keller RW
Am J Physiol Cell Physiol; 2011 Oct; 301(4):C814-22. PubMed ID: 21734190
[TBL] [Abstract][Full Text] [Related]
20. Hypo-osmotic swelling modifies glutamate-glutamine cycle in the cerebral cortex and in astrocyte cultures.
Hyzinski-García MC; Vincent MY; Haskew-Layton RE; Dohare P; Keller RW; Mongin AA
J Neurochem; 2011 Jul; 118(1):140-52. PubMed ID: 21517854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
